menu search

Synairgen hires full-time chief medical officer as drug development ramps up

Synairgen PLC (AIM:SNG, OTC:SYGGF) has appointed seasoned pharmaceutical physician and drug developer Dr. Marc...

October 3, 2023, 2:27 am

Natamycin market is expected to reach a valuation of us$ 102.7 mn by the end of 2032 | future market insights, inc.

The North America Natamycin Industry is expected to register 6.4% CAGR between 2022 and 2032. Overall natamycin demand across China is projected to gr...

January 4, 2023, 10:30 am


Search within

Pages Search Results: